High levels of OPN expression in tissue and blood have been reported in patients with cancer [36, 37], infectious diseases such as HAD [38, 39], autoimmune disorders including multiple sclerosis and rheumatoid arthritis [40–42], obesity and diabetes [43, 44]. This evidence concerns the gene SPP1 and obesity disorder.